HRTX
HRTX
NASDAQ · Biotechnology

Heron Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks
$0.29
0.00 (-0.82%)
As of Sep 28, 10:14 PM ET ·
Analyst Consensus
Strong Sell
7
Analysts
Moderate
Coverage
Buy 0 0%
Hold 4 57%
Sell 3 43%
Price Target
Analyst Price Target +7,717.0% upside
Low Target $15.42
Average Target $22.81
High Target $25.92
Current Price $0.29
Current
$0.29
Target
$22.81
$15.42 $22.81 avg $25.92
Scenario Analysis
Bear Case
$15.42
5,184.4%
Low target
Base Case
$22.81
+7,717.0%
Avg target
Bull Case
$25.92
+8,782.8%
High target
Risk/Reward
1.7x
Balanced
Price in Context
52-Week High
$1.58
-81.5% from high
52-Week Low
$0.26
+11.8% from low
Target vs 52W High
$22.81
+1,343.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 39 82% $257.58 -3.3%
AMGN
Amgen Inc
 Hold 43 47% $190.87 -54.4%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +138.3%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 36 81% $438.34 -16.9%
REGN
Regeneron Pharmaceuticals
 Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
 Hold 30 37% $149.45 -24.2%
NTRA
Natera Inc
 Strong Buy 30 87% $142.91 -65.3%
RVMD
Revolution Medicines Inc
 Strong Buy 28 93% $114.11 -43.4%